Letter

Nature 442, 585-589 (3 August 2006) | doi:10.1038/nature04922; Received 27 February 2006; Accepted 3 May 2006; Published online 28 June 2006

The physical basis of how prion conformations determine strain phenotypes

Motomasa Tanaka1,2, Sean R. Collins1, Brandon H. Toyama1 and Jonathan S. Weissman1

A principle that has emerged from studies of protein aggregation is that proteins typically can misfold into a range of different aggregated forms. Moreover, the phenotypic and pathological consequences of protein aggregation depend critically on the specific misfolded form1, 2. A striking example of this is the prion strain phenomenon, in which prion particles composed of the same protein cause distinct heritable states3. Accumulating evidence from yeast prions such as [PSI+] and mammalian prions argues that differences in the prion conformation underlie prion strain variants3, 4, 5, 6, 7. Nonetheless, it remains poorly understood why changes in the conformation of misfolded proteins alter their physiological effects. Here we present and experimentally validate an analytical model describing how [PSI+] strain phenotypes arise from the dynamic interaction among the effects of prion dilution, competition for a limited pool of soluble protein, and conformation-dependent differences in prion growth and division rates. Analysis of three distinct prion conformations of yeast Sup35 (the [PSI+] protein determinant) and their in vivo phenotypes reveals that the Sup35 amyloid causing the strongest phenotype surprisingly shows the slowest growth. This slow growth, however, is more than compensated for by an increased brittleness that promotes prion division. The propensity of aggregates to undergo breakage, thereby generating new seeds, probably represents a key determinant of their physiological impact for both infectious (prion) and non-infectious amyloids.

  1. Howard Hughes Medical Institute, Department of Cellular and Molecular Pharmacology, University of California–San Francisco and California Institute for Quantitative Biomedical Research, San Francisco, California 94143, USA
  2. PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho Kawaguchi, Saitama 332-0012, Japan

Correspondence to: Jonathan S. Weissman1 Correspondence and requests for information should be addressed to J.S.W. (Email: weissman@cmp.ucsf.edu).

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Understanding the diversity of prions

Nature Cell Biology News and Views (01 Apr 2004)

Prion strains under the magnifying glass

Nature Structural & Molecular Biology News and Views (01 Oct 2007)

See all 8 matches for News And Views

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT